Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:27 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 369 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Bone Mass Clear all

Conditions: Osteoporosis
Interventions: Alendronate; Drug
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: Not listed
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Osteopenia
Interventions: Lunar Prodigy (GEHC), Lunar iDXA (GEHC), Discovery A (Hologic; Device
Lead sponsor: GE Healthcare; Industry
Eligibility: 20 Years and older
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Lakewood, Colorado

Conditions: Breast Cancer, Osteoporosis
Interventions: biologic sample preservation procedure, dual x-ray absorptometry; Other · Procedure
Lead sponsor: NCIC Clinical Trials Group; Network
Eligibility: 35 Years and older · Female only
Enrollment: 238 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2013
U.S. locations: 13
States / cities: Torrance, California • Washington D.C., District of Columbia • Scarborough, Maine + 9 more

Conditions: Aphakia
Interventions: Artisan Aphakia Intraocular Lens; Device
Lead sponsor: Ophtec USA; Industry
Eligibility: 2 Years to 21 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2025
U.S. locations: 18
States / cities: Phoenix, Arizona • Los Angeles, California • Indianapolis, Indiana + 15 more

Conditions: Breast Cancer, Bone Diseases
Interventions: Vitamin D; Drug
Lead sponsor: Mark Pegram; Other
Eligibility: 18 Years to 85 Years · Female only
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Stanford, California

Conditions: Prostate Cancer
Interventions: risedronate, Placebo risedronate oral tablet; Drug
Lead sponsor: UConn Health; Other
Eligibility: 55 Years to 85 Years · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Breast Neoplasms
Interventions: Exemestane, Calcium carbonate, Vitamin D; Drug · Dietary Supplement
Lead sponsor: Georgetown University; Other
Eligibility: Female only
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2011
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Bethesda, Maryland

Conditions: Osteoporosis
Interventions: rhBMP-2/CPM injection and bisphosphonates, calcium, and vitamin D (oral bisphosphonate therapy), bisphosphonates, calcium, and vitamin D; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 65 Years to 85 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 28
States / cities: Phoenix, Arizona • Tucson, Arizona • Sacramento, California + 15 more

Conditions: Marfan Syndrome
Interventions: Tele-Clinic Visits Using Parent-Acquired Echos; Other
Lead sponsor: Stanford University; Other
Eligibility: 5 Years to 19 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Marfan Syndrome
Interventions: Losartan Potassium, Atenolol; Drug
Lead sponsor: Carelon Research; Other
Eligibility: 6 Months to 25 Years
Enrollment: 608 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 24
States / cities: Los Angeles, California • Palo Alto, California • San Diego, California + 18 more

Conditions: Healthy Apheresis Donors
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years to 80 Years
Enrollment: 273 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Spinal Cord Injury, Osteoporosis
Interventions: Fosamax, Placebo; Drug
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years to 100 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 2
States / cities: Rochester, New York

Conditions: Osteoporosis
Interventions: Calcium rich diet, Weight bearing exercise; Behavioral
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 9 Years to 10 Years · Female only
Enrollment: 107 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 1998
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Cervical Cancer, Endometrial Cancer, Vaginal Cancer
Interventions: CT or MRI + Blood Test; Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: Female only
Enrollment: 239 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Osteoporosis, Post-menopausal
Interventions: Romosozumab, Alendronate (Fosamax), Placebo Romosozumab, Placebo Alendronate; Drug
Lead sponsor: University of Pittsburgh; Other
Eligibility: 65 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Hemophilia A
Interventions: assessment of joint health and bone density; Other
Lead sponsor: Washington Institute for Coagulation; Other
Eligibility: 16 Years and older · Male only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 4
States / cities: Los Angeles, California • San Diego, California • San Antonio, Texas + 1 more

Conditions: Bone Health, Osteoporosis
Interventions: Yoga Group; Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 35 Years to 50 Years · Female only
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Norman, Oklahoma

Conditions: Metabolism
Interventions: Exercise; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 3 Years to 7 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 2
States / cities: Birmingham, Alabama

Conditions: Depression, Healthy, Osteopenia, Osteoporosis
Interventions: Alendronate; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 21 Years to 45 Years · Female only
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2007
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Osteoporosis, Cardiac Transplantation
Interventions: Alendronate, Calcitriol, Placebo Alendronate, Placebo Calcitriol; Drug
Lead sponsor: Columbia University; Other
Eligibility: 20 Years to 70 Years
Enrollment: 149 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2002
U.S. locations: 2
States / cities: New York, New York

Conditions: Multiple Myeloma
Interventions: Sotatercept, Placebo; Drug
Lead sponsor: Rebecca Silbermann; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Bone Mineral Density
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 65 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Breast Cancer, Osteoporosis
Interventions: Bone Mineral Density; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: Female only
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 3
States / cities: Basking Ridge, New Jersey • Commack, New York • New York, New York

Conditions: Spinal Cord Injury
Interventions: NMES, Vitamin D, Passive movement; Device · Drug · Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Richmond, Virginia

Search by objective public record fields.

Treatment of Childhood Osteoporosis With Alendronate (Fosamax)

DXA Precision and Accuracy Comparison Study

Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3

Artisan Aphakia Lens for the Correction of Aphakia in Children

Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption

Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer

Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer

Study Evaluating Changes In Bone Mineral Density (BMD), And Safety Of Rhbmp-2/CPM In Subjects With Decreased BMD

Tele-Clinic Visits in Pediatric Marfan Patients Using Parental Echo: The Future?

Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome

Citrate Effects and Bone Density in Long-Term Apheresis Donors

Pilot Study of Fosamax in Spinal Cord Injury

Bone Development in Adolescent Girls: Effects of Calcium and Exercise

Pelvic Fractures and Radiation Therapy for Cervical Cancer

Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes

Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A

Effects of Yoga on Bone Metabolism in Premenopausal Women

Critical Periods of Exercise

Bone Loss in Premenopausal Women With Depression

Osteoporosis Prevention After Heart Transplant

A Phase IIa Study of Sotatercept on Bone Mass and Turnover in Patients With Multiple Myeloma

Bone Quality by vQCT and HR-pQCT:Translation to Multi-center Clinical Research

Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer

Effects of Electrical Stimulation and Vitamin D Supplementation on Bone Health Following Spinal Cord Injury.